Wenju Chen, Jiayu Niu, Shusheng Wu, Huijun Xu, Lulu Cao, Mengge Li, Huiqin Luo, Lihong Ke, Ying Yan, Gang Wang, Yifu He. "Phase II study of bevacizumab plus trifluridine/tipiracil and irinotecan as second-line therapy for RAS wild-type metastatic colorectal cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e15578